Who is sponsoring NCT05677958?

NCT05677958 is sponsored by Nutricia Research.

What drugs are being tested in NCT05677958?

Interventions in NCT05677958: 125 mL Fortimel/Nutridrink Compact Protein.

What condition does NCT05677958 study?

NCT05677958 studies Colorectal Cancer, Lung Cancer.

Is NCT05677958 still recruiting?

NCT05677958 is currently completed. Last updated 10 January 2023.

Last reviewed 2023-01-10 · How we verify

NCT05677958: PROTEOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional Supplement

Completed NA Last updated 10 January 2023

What this trial tests

NA trial testing 125 mL Fortimel/Nutridrink Compact Protein in Colorectal Cancer in 126 participants. Completed in 17 December 2021.

Timeline

17 January 2019

Primary endpoint
17 December 2021

17 December 2021

Quick facts

Lead sponsor	Nutricia Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	126
Start date	17 January 2019
Primary completion	17 December 2021
Estimated completion	17 December 2021
Sites	14 locations across Netherlands, Belgium, Estonia, Poland, Norway, Lithuania, Portugal

Drugs / interventions tested

125 mL Fortimel/Nutridrink Compact Protein

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →
Lung Cancer — all drugs for Lung Cancer →

Sponsor

Nutricia Research — full company profile →

Who can join

18 and older, any sex, with Colorectal Cancer or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PROTEOS study is an randomized controlled, open label, parallel-group, multi-centre and multicounty interventional study to assess the acceptance and implementation of Compact Protein, a low volume, energy dense and high protein oral nutritional support in clinical practice according to the ESPEN guidelines in colorectal and lung cancer patients undergoing chemo(radio)- or immunotherapy treatment.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential.
Xiao YL, Gong Y, Qi YJ, Shao ZM, et al · · 2024 · cited 120× · PMID 38462638 · DOI 10.1038/s41392-024-01771-x
High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study.
Dingemans AM, van Walree N, Schramel F, Soud MY, et al · · 2023 · cited 13× · PMID 38140289 · DOI 10.3390/nu15245030

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other Nutricia Research trials

Trials by the same sponsor.

NCT07243743 — Assessment of the Glycemic Responses to Nutritional Products-INQ-2526 · NA · completed
NCT06797349 — Glin4: Assessment of the Glycemic Responses to Nutritional Products · Phase 4 · completed
NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05677958 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
Last refreshed: 10 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05677958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing